RVL Pharmaceuticals
RVLP
#10311
Rank
โ‚น0.27 B
Marketcap
โ‚น2.43
Share price
-32.05%
Change (1 day)
N/A
Change (1 year)

EPS for RVL Pharmaceuticals (RVLP)

EPS in 2023 (TTM): -โ‚น57.48

According to RVL Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น60.35. In 2022 the company made an earnings per share (EPS) of -โ‚น48.28 an increase over its 2021 EPS that were of -โ‚น81.91.

EPS history for RVL Pharmaceuticals from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น57.4819.05%
2022-โ‚น48.28-41.05%
2021-โ‚น81.91-26.36%
2020-โ‚น111.22-75.05%
2019-โ‚น445.76146.15%
2018-โ‚น181.09